Macquarie Group’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-2,680
| Closed | -$18.3K | – | 1731 |
|
2024
Q2 | $18.3K | Buy |
+2,680
| New | +$18.3K | ﹤0.01% | 1635 |
|
2022
Q4 | – | Sell |
-465
| Closed | -$22K | – | 1927 |
|
2022
Q3 | $22K | Sell |
465
-562
| -55% | -$26.6K | ﹤0.01% | 2155 |
|
2022
Q2 | $32K | Hold |
1,027
| – | – | ﹤0.01% | 2171 |
|
2022
Q1 | $42 | Hold |
1,027
| – | – | ﹤0.01% | 2191 |
|
2021
Q4 | $45K | Sell |
1,027
-25,495
| -96% | -$1.12M | ﹤0.01% | 2186 |
|
2021
Q3 | $1.33M | Hold |
26,522
| – | – | ﹤0.01% | 1509 |
|
2021
Q2 | $1.67M | Buy |
26,522
+1,901
| +8% | +$120K | ﹤0.01% | 1469 |
|
2021
Q1 | $2.29M | Buy |
24,621
+2,798
| +13% | +$260K | ﹤0.01% | 1158 |
|
2020
Q4 | $1.96M | Buy |
21,823
+2,328
| +12% | +$209K | ﹤0.01% | 1108 |
|
2020
Q3 | $2.01M | Sell |
19,495
-7,684
| -28% | -$794K | ﹤0.01% | 1034 |
|
2020
Q2 | $2.15M | Sell |
27,179
-983
| -3% | -$77.7K | ﹤0.01% | 991 |
|
2020
Q1 | $1.63M | Sell |
28,162
-4,229
| -13% | -$245K | ﹤0.01% | 970 |
|
2019
Q4 | $1.75M | Buy |
32,391
+2,856
| +10% | +$154K | ﹤0.01% | 1077 |
|
2019
Q3 | $1.54M | Sell |
29,535
-1,359
| -4% | -$71K | ﹤0.01% | 1095 |
|
2019
Q2 | $1.49M | Buy |
30,894
+3,608
| +13% | +$174K | ﹤0.01% | 1103 |
|
2019
Q1 | $1.38M | Buy |
27,286
+3,600
| +15% | +$182K | ﹤0.01% | 1096 |
|
2018
Q4 | $1.4M | Sell |
23,686
-3,072
| -11% | -$182K | ﹤0.01% | 1058 |
|
2018
Q3 | $1.76M | Sell |
26,758
-4,699
| -15% | -$309K | ﹤0.01% | 1038 |
|
2018
Q2 | $1.59M | Buy |
31,457
+1,297
| +4% | +$65.5K | ﹤0.01% | 1059 |
|
2018
Q1 | $1.59M | Sell |
30,160
-8,867
| -23% | -$467K | ﹤0.01% | 1062 |
|
2017
Q4 | $1.81M | Sell |
39,027
-2,546
| -6% | -$118K | ﹤0.01% | 1054 |
|
2017
Q3 | $1.68M | Buy |
41,573
+15,604
| +60% | +$631K | ﹤0.01% | 1038 |
|
2017
Q2 | $881K | Buy |
25,969
+197
| +0.8% | +$6.68K | ﹤0.01% | 1198 |
|
2017
Q1 | $748K | Sell |
25,772
-728
| -3% | -$21.1K | ﹤0.01% | 1241 |
|
2016
Q4 | $870K | Buy |
+26,500
| New | +$870K | ﹤0.01% | 1194 |
|